To test the impact of CXCR4 blockade with either AMD3100 or MSX-122 on development of radiation-induced PF, we administered AMD3100, 10 mg/kg, s.c. or MSX-122, 10 mg/kg i.p. for 20-weeks. This evidence concerns the gene CXCR4 and pemphigus foliaceus.